503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
2.14%
Revenue growth below 50% of ORCL's 40.94%. Michael Burry would check for competitive disadvantage risks.
1.82%
Cost growth less than half of ORCL's 20.82%. David Dodd would verify if cost advantage is structural.
2.18%
Gross profit growth below 50% of ORCL's 46.65%. Michael Burry would check for structural issues.
0.04%
Margin expansion below 50% of ORCL's 4.05%. Michael Burry would check for structural issues.
20.55%
Similar R&D growth to ORCL's 20.03%. Walter Schloss would investigate industry innovation requirements.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
5.50%
Operating expenses growth less than half of ORCL's 36.26%. David Dodd would verify sustainability.
4.91%
Total costs growth less than half of ORCL's 31.92%. David Dodd would verify sustainability.
No Data
No Data available this quarter, please select a different quarter.
-5.71%
D&A reduction while ORCL shows 22.31% growth. Joel Greenblatt would examine efficiency.
-3.39%
EBITDA decline while ORCL shows 64.01% growth. Joel Greenblatt would examine position.
-0.91%
EBITDA margin decline while ORCL shows 14.04% growth. Joel Greenblatt would examine position.
-3.10%
Operating income decline while ORCL shows 74.03% growth. Joel Greenblatt would examine position.
-5.13%
Operating margin decline while ORCL shows 23.47% growth. Joel Greenblatt would examine position.
-65.12%
Other expenses reduction while ORCL shows 12.50% growth. Joel Greenblatt would examine advantage.
-7.60%
Pre-tax income decline while ORCL shows 73.40% growth. Joel Greenblatt would examine position.
-9.54%
Pre-tax margin decline while ORCL shows 23.03% growth. Joel Greenblatt would examine position.
-8.67%
Tax expense reduction while ORCL shows 73.45% growth. Joel Greenblatt would examine advantage.
-7.07%
Net income decline while ORCL shows 73.38% growth. Joel Greenblatt would examine position.
-9.02%
Net margin decline while ORCL shows 23.01% growth. Joel Greenblatt would examine position.
-12.50%
EPS decline while ORCL shows 73.50% growth. Joel Greenblatt would examine position.
-12.50%
Diluted EPS decline while ORCL shows 73.50% growth. Joel Greenblatt would examine position.
6.44%
Share count increase while ORCL reduces shares. John Neff would investigate differences.
6.44%
Diluted share increase while ORCL reduces shares. John Neff would investigate differences.